1. Home
  2. FBIO vs PFX Comparison

FBIO vs PFX Comparison

Compare FBIO & PFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$2.75

Market Cap

91.0M

Sector

Health Care

ML Signal

HOLD

PFX

PhenixFIN Corporation

N/A

Current Price

$42.97

Market Cap

85.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
FBIO
PFX
Founded
2006
2010
Country
United States
United States
Employees
78
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
91.0M
85.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FBIO
PFX
Price
$2.75
$42.97
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
494.2K
1.5K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
3.57%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$55.22
N/A
Revenue Next Year
$40.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$38.30
52 Week High
$4.53
$53.59

Technical Indicators

Market Signals
Indicator
FBIO
PFX
Relative Strength Index (RSI) 47.30 51.44
Support Level $2.53 $41.83
Resistance Level $2.92 $45.03
Average True Range (ATR) 0.19 0.55
MACD -0.01 -0.13
Stochastic Oscillator 8.46 41.12

Price Performance

Historical Comparison
FBIO
PFX

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

Share on Social Networks: